Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice by de Picciotto, Natalie E et al.





reverses vascular dysfunction and oxidative stress
with aging in mice
Natalie E. de Picciotto
University of Colorado, Boulder
Lindsey B. Gano
University of Colorado, Boulder
Lawrence C. Johnson
University of Colorado, Boulder
Christopher R. Martens
University of Colorado, Boulder
Amy L. Sindler
University of Colorado, Boulder
See next page for additional authors
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
de Picciotto, Natalie E.; Gano, Lindsey B.; Johnson, Lawrence C.; Martens, Christopher R.; Sindler, Amy L.; Mills, Kathryn F.; Imai,
Shin-ichiro; and Seals, Douglas R., ,"Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative
stress with aging in mice." Aging Cell.15,3. 522-530. (2016).
http://digitalcommons.wustl.edu/open_access_pubs/4891
Authors
Natalie E. de Picciotto, Lindsey B. Gano, Lawrence C. Johnson, Christopher R. Martens, Amy L. Sindler,
Kathryn F. Mills, Shin-ichiro Imai, and Douglas R. Seals
This open access publication is available at Digital Commons@Becker: http://digitalcommons.wustl.edu/open_access_pubs/4891
Nicotinamide mononucleotide supplementation reverses
vascular dysfunction and oxidative stress with aging in mice
Natalie E. de Picciotto,1 Lindsey B. Gano,1‡,*
Lawrence C. Johnson,1‡ Christopher R. Martens,1
Amy L. Sindler,1† Kathryn F. Mills,2 Shin-ichiro Imai2 and
Douglas R. Seals1
1Department of Integrative Physiology, University of Colorado Boulder,
Boulder, CO, USA
2Department of Developmental Biology, Washington University School of
Medicine, St. Louis, MO, USA
Summary
We tested the hypothesis that supplementation of nicotinamide
mononucleotide (NMN), a key NAD+ intermediate, increases
arterial SIRT1 activity and reverses age-associated arterial dys-
function and oxidative stress. Old control mice (OC) had
impaired carotid artery endothelium-dependent dilation (EDD)
(60  5% vs. 84  2%), a measure of endothelial function, and
nitric oxide (NO)-mediated EDD (37  4% vs. 66  6%), com-
pared with young mice (YC). This age-associated impairment in
EDD was restored in OC by the superoxide (O2 ) scavenger
TEMPOL (82  7%). OC also had increased aortic pulse wave
velocity (aPWV, 464  31 cm s1 vs. 337  3 cm s1) and elastic
modulus (EM, 6407  876 kPa vs. 3119  471 kPa), measures of
large elastic artery stiffness, compared with YC. OC had greater
aortic O2 production (2.0  0.1 vs. 1.0  0.1 AU), nitrotyrosine
abundance (a marker of oxidative stress), and collagen-I, and
reduced elastin and vascular SIRT1 activity, measured by the
acetylation status of the p65 subunit of NFjB, compared with
YC. Supplementation with NMN in old mice restored EDD
(86  2%) and NO-mediated EDD (61  5%), reduced aPWV
(359  14 cm s1) and EM (3694  315 kPa), normalized O2
production (0.9  0.1 AU), decreased nitrotyrosine, reversed
collagen-I, increased elastin, and restored vascular SIRT1 activity.
Acute NMN incubation in isolated aortas increased NAD+
threefold and manganese superoxide dismutase (MnSOD) by
50%. NMN supplementation may represent a novel therapy to
restore SIRT1 activity and reverse age-related arterial dysfunc-
tion by decreasing oxidative stress.
Key words: arterial stiffness; endothelial dysfunction; NAD+;
oxidative stress; SIRT1.
Introduction
Cardiovascular diseases (CVD) remain the leading cause of morbidity and
mortality in developed nations (Mortality & Causes of Death, 2014), and
advancing age is the primary risk factor for CVD (Lakatta & Levy, 2003).
The number of older adults in the developed world is expected to at least
double by 2050 (Petsko, 2008), and this is associated with projections of
marked increases in CVD burden (Heidenreich et al., 2011). Therefore,
there is an urgent need to develop treatments that reduce the risk of
CVD with aging.
Two key antecedents and independent predictors of clinical CVD in
older adults are vascular endothelial dysfunction, assessed by endothe-
lium-dependent dilation (EDD), and large elastic artery stiffness, mea-
sured by aortic pulse wave velocity (aPWV) (Lakatta & Levy, 2003;
Deanfield et al., 2007; Yeboah et al., 2007; Mitchell et al., 2010). A
common mechanism that contributes to both vascular endothelial
dysfunction and large elastic artery stiffness with aging is excessive
superoxide-associated vascular oxidative stress (Seals et al., 2011;
Fleenor et al., 2012a; Bachschmid et al., 2013). Increased vascular
production of superoxide occurs with aging and reduces the bioavail-
ability of the vasoprotective and vasodilatory molecule nitric oxide (NO),
while also causing alterations in major structural proteins (collagen and
elastin) in the large elastic arteries (i.e., the aorta and carotid arteries)
(Deanfield et al., 2007; Fleenor et al., 2010; Seals et al., 2014). These
changes contribute directly to age-related endothelial dysfunction and
increased arterial stiffness (Lakatta & Levy, 2003; Seals et al., 2011). As
such, treatments that reduce the excessive superoxide production in
aging arteries hold the potential for improving age-associated vascular
dysfunction.
We have previously shown that lifelong caloric restriction (CR), as well
as short-term CR in old animals, prevents or reverses endothelial
dysfunction and large elastic artery stiffening by reducing superoxide
production, increasing NO bioavailability, and modifying structural
proteins (Rippe et al., 2010; Donato et al., 2013). However, because
adherence to CR is not practical for most humans, there is growing
interest in pharmacological therapies that may induce the benefits of CR.
In this context, the mammalian SIRT1, one of seven members in the
sirtuin family of protein deacetylases/deacylases, is a nicotinamide
adenine dinucleotide (NAD+)-dependent deacetylase that acts as a
metabolic energy sensor implicated in several of the beneficial effects of
CR, including reduced oxidative stress (Boily et al., 2008; Merksamer
et al., 2013). Our previous work shows that reduced SIRT1 expression
and activity is a key mechanism mediating impaired EDD in aging arteries
(Rippe et al., 2010; Donato et al., 2011; Gano et al., 2014), and our
recent findings indicate that pharmacological activation of SIRT1 with
the compound SRT1720 improves EDD in old mice in part by reducing
oxidative stress (Gano et al., 2014).
Supplementation with nicotinamide mononucleotide (NMN), a key
NAD+ intermediate, activates SIRT1 and improves metabolic and stress
responses with aging in mice (Yoshino et al., 2011; Gomes et al., 2013).
Thus, NMN is viewed as a promising therapy for age-associated
physiological dysfunction and disease (Imai, 2010; Yoshino et al.,
2011). However, it is unknown whether NMN supplementation can
increase arterial SIRT1 activity, reduce vascular oxidative stress, and
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reverse vascular dysfunction with aging. In the present study, we tested
this hypothesis, while also assessing the effects of NMN on vascular
superoxide production, NO bioavailability, and collagen and elastin
expression. Acetylation status of the p65 subunit of nuclear factor kappa
B (NFjB), a well-established target of SIRT1, was used to determine
activation of the enzyme, as described previously (Yoshino et al., 2011;
Gano et al., 2014).
Results
Animal characteristics and NMN intake
Selected morphological characteristics are shown in Table 1. There were
no differences in body mass across the four groups. We observed an
age-related increase in heart mass and a decrease in fat and muscle
mass, which were not altered with NMN treatment. All animals
consumed the same quantity of food throughout the duration of the
study, and average NMN intake was similar in both young and old
treated groups (data not shown).
NMN treatment restores maximum EDD and NO-mediated
EDD in old mice
Baseline carotid artery diameters (lm) assessed ex vivo were greater in
old mice (controls: 480  17; treated: 478  9) vs. young mice
(controls: 424  4; treated: 432  5), as we have previously reported
(Sindler et al., 2011). NMN supplementation had no effect on baseline
carotid artery diameters. Maximum EDD to acetylcholine assessed ex vivo
was lower in old control compared with young control mice and was
mediated in part by a diminished NO dilatory influence, as indicated by a
smaller reduction in EDD in the presence vs. absence of the NO synthase
inhibitor N-G-nitro-L-arginine-methyl ester (L-NAME) (Fig. 1A,B). NMN
supplementation rescued EDD in old mice by restoring NO-mediated
dilation, but had no effect in young treated animals (Fig. 1A,B). There
were no differences in maximal EDD or NO-mediated EDD in young and
old treated animals vs. young controls (Fig. 1 A,B). Endothelium-
independent dilation to the NO donor sodium nitroprusside, a control to
assess vascular smooth muscle sensitivity to NO, was not different
among the groups (Fig. 1C).
NMN reduces vascular oxidative stress
Ex vivo incubation with the superoxide dismutase mimetic, 4-Hydroxy-
2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPOL), restored EDD in carotid
arteries of old control animals, while having no effect in the other groups
(Fig. 2A), indicating excessive superoxide-mediated endothelial
dysfunction with aging. To further assess the influence of aging and
NMN treatment on oxidative stress in arteries, aortas were used because
of the greater amount of tissue provided for biochemical assay, as
described previously (Sindler et al., 2011; Donato et al., 2013; LaRocca
et al., 2013; Gano et al., 2014). Consistent with the results of the
pharmacological-function experiments with TEMPOL, compared with
young mice, aortas from old animals exhibited increased superoxide
production, directly assessed by electron paramagnetic resonance (EPR)
spectroscopy (Fig. 2B), and increased nitrotyrosine abundance (Fig. 2C),
a marker of oxidative protein modification and cellular footprint of
oxidative stress. NMN treatment ameliorated the age-related increase
Table 1 Animal Characteristics
YC OC YNMN ONMN
Body mass (g) 30.1  0.7 30.3  0.6 28.0  0.9 30.8  0.6
Heart mass (mg) 145  6 176  7* 139  7 182  8*
Quad mass (mg) 176  5 151  4* 185  6 146  6*
Gastroc mass (mg) 151  3 124  3* 148  8 126  2*
WAT mass (mg) 730  65 472  41* 600  35 430  50*
SubQ fat mass (mg) 334  32 207  17* 252  16 201  23*
Values are mean  SEM *P < 0.05 vs. YC. n = 13–19/group.
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Fig. 1 Endothelium-dependent, nitric oxide (NO)-dependent, and endothelium-
independent dilation. (A) Dose–responses to the endothelium-dependent dilator
acetylcholine (ACh) in young and old control (YC and OC) and young and old
NMN-supplemented (YNMN and ONMN) mice (n = 13–22 per group). (B) NO-
dependent dilation (Max DilationACh  Max DilationACh + L-NAME) (n = 5–12
per group). (C) Dose–responses to the endothelium-independent dilator sodium
nitroprusside (SNP) (n = 7–22 per group). Values are mean  SEM. *P < 0.05 vs.
all.
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in superoxide production (Fig. 2B) and markedly reduced aortic
nitrotyrosine abundance in old mice (Fig. 2C), while having no significant
effect in young mice. Together, these data indicate that NMN reverses
age-associated oxidative stress in arteries, which, in turn, mediates
improvements in endothelial function.
NMN treatment normalizes aortic stiffness in old mice
Large elastic artery stiffness, as assessed in vivo by aPWV, was greater in
old control compared with young control mice (Fig. 3A). NMN treatment
reversed the age-associated increase in aPWV in old mice, while having
no effect in young mice (Fig. 3A). Similarly, the elastic modulus, an
in vitro index of intrinsic arterial stiffness, was higher in old controls
compared with young and was normalized with NMN supplementation
(Fig. 3B). Thoracic aortas from old control animals exhibited markedly
increased collagen type I expression (Fig. 3C) and diminished elastin
(Fig. 3D) compared with young controls. In old mice, NMN reduced
arterial collagen type I to levels of young mice (Fig. 3C), and increased
elastin to levels not significantly different from young mice (Fig. 3D).
Together, these observations indicate that NMN reverses large elastic
artery stiffening with aging, in part by normalizing collagen and partially
preserving elastin in the arterial wall.
NMN activates arterial SIRT1
Mean levels of aortic SIRT1 expression were ~50% lower in the old
animals, compared with young mice, although the difference did not
reach statistical significance (Fig. 4A). NMN supplementation increased
SIRT1 protein expression in young animals and tended to increase SIRT1
in old animals (Fig. 4A). The p65 subunit of NFjB is a major target of
SIRT1 and is deacetylated in response to SIRT1 activation (Yeung et al.,
2004). As such, SIRT1 activation was determined by assessing the ratio of
acetylated to total NFjB (p65 subunit). This ratio was markedly higher in
aorta of old control animals compared with young controls, indicating
that aortic SIRT1 activity was reduced with aging. Most importantly,
NMN supplementation restored aortic SIRT1 activity in old animals
(Fig. 4B).
We were unable to detect an increase in aortic NAD+ concentration in
animals chronically supplemented with NMN. This was possibly because
the mice were consuming small amounts of NMN in the drinking water
throughout the day, and although this NMN was taken up by the
vascular tissue, we posit that the small quantities of NAD+ produced
were rapidly metabolized. To determine whether NMN is capable of
increasing arterial NAD+ bioavailability, we incubated isolated aortic
tissue, in vitro. Incubation of aortic segments from young mice with
NMN (100 lM) for 48 h resulted in a threefold higher production of
NAD+ compared with vessels incubated in Dulbecco’s modified Eagle
medium (DMEM) control media (Fig. 5A).
We also took advantage of these in vitro experiments to gain insight
into a likely mechanism by which NMN may have reduced vascular
oxidative stress in vivo. To do so, we assessed the mitochondrial
antioxidant, manganese superoxide dismutase (MnSOD), which is
upregulated in response to SIRT1 activation, possibly through stimulation
of peroxisome proliferator-activated receptor-gamma coactivator-1alpha
(PGC1a) (Pfluger et al., 2008). We found that aortas from old mice
incubated in NMN for 48 h had a 50% higher staining of MnSOD
compared with aortas incubated in control media (Fig. 5B).
Collectively, these data suggest that NMN is capable of increasing
NAD+ bioavailability in the vasculature and this likely explains the
observed increase in arterial SIRT1 activity. Because MnSOD is upregu-
lated in arteries incubated in NMN, this may also represent a mechanism
by which oxidative stress was reduced in old animals supplemented with
NMN in the drinking water.
Fig. 2 Vascular oxidative stress. (A) Maximal dose–response to the endothelium-
dependent dilator acetylcholine (ACh) in young and old control (YC and OC) and
young and old NMN-supplemented (YNMN and ONMN) mice in the presence or
absence of TEMPOL (n = 5–9 per group) *P < 0.05 vs. TEMPOL. (B) Superoxide
production, assessed by electron paramagnetic resonance (EPR). Values are
normalized to YC mean value. Representative EPR signal below (n = 4–9 per
group). (C) Nitrotyrosine (NT) abundance in aorta. Data are expressed relative to
a-smooth muscle actin and normalized to YC mean value. Representative Western
blot images below (n = 4–6 per group). Values are mean  SEM. *P < 0.05 vs. all;
# P < 0.05 vs. YC.
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Discussion
In the present study, 8 weeks of NMN supplementation restored a
marker of arterial SIRT1 activity and ameliorated age-associated
endothelial dysfunction and large elastic artery stiffening in male
C57Bl/6 mice. These improvements were associated with restored NO
bioavailability, reduced oxidative stress, and complete or partial normal-
ization of structural proteins in the arterial wall. Overall, our findings
provide the first evidence supporting the promising translational
potential of NMN supplementation for the treatment of arterial aging.
NMN improves NO-mediated EDD and reduces arterial
oxidative stress
Endothelial dysfunction is the major antecedent to atherosclerosis, a
predictor of clinical CVD risk, and is linked to many common disorders of
aging including cognitive impairments, Alzheimer’s disease, motor
dysfunction, insulin resistance, and sarcopenia (Heitzer et al., 2001;
Gokce et al., 2002; Lakatta & Levy, 2003; Widlansky et al., 2003; Seals
et al., 2011, 2014). We have previously demonstrated that arterial SIRT1
activity is reduced with aging and contributes to the age-related
impairment in endothelial function (Donato et al., 2011; Gano et al.,
2014). We and others also have shown that lifelong CR prevents (Csiszar
et al., 2009; Donato et al., 2013) and short-term CR reverses (Rippe
et al., 2010) the age-associated decline in endothelial function and that
these effects are associated with enhanced arterial SIRT1 activity.
Consistent with these observations, we recently found that 4 weeks of
treatment with the SIRT1 activator SRT1720 restores endothelial function
(i.e., EDD) in old mice (Gano et al., 2014).
In the present study, we demonstrate a reversal of age-associated
endothelial dysfunction by oral NMN supplementation. As established in
our previous work (Rippe et al., 2010; Sindler et al., 2011; Fleenor et al.,
2013; LaRocca et al., 2013), aging in the control animals was associated
with an impairment in ex vivo carotid artery EDD in response to
Fig. 3 Large elastic artery stiffness. (A)
Aortic pulse wave velocity (aPWV) in young
and old control (YC and OC) and young
and old NMN-supplemented (YNMN and
ONMN) mice (n = 5–9 per group). (B)
Elastic modulus (n = 5–6 per group). (C)
Total collagen 1 (Col 1) expression in aorta
(n = 4–9 per group). (D) Total elastin
expression in aorta. Values normalized to
YC mean value. Representative images
below (n = 4–11 per group). Values are
mean  SEM. Bars = 100 lm. *P < 0.05
vs. all; # P < 0.05 vs. YC.
Fig. 4 SIRT1 expression and activity. (A)
SIRT1 expression in aorta of young and old
control (YC and OC) and young and old
NMN-supplemented (YNMN and ONMN)
mice (n = 5–7 per group). (B) Ratio of
acetylated to total NFjB in aorta (n = 5–11
per group). Data are expressed relative to a-
smooth muscle actin and normalized to YC
mean value. Representative Western blot
images below. Values are mean  SEM.
#P < 0.05 vs. YC; †P < 0.05 vs. OC.
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acetylcholine due to reduced NO-mediated dilation (Fig. 1A,B). The
latter was determined as the difference in EDD in the absence vs.
presence of NO production achieved by co-administration of the NO
synthase inhibitor, L-NAME. NMN supplementation completely restored
EDD by restoring NO-mediated dilation. The improvement in EDD with
NMN treatment in old mice was not due to an increase in vascular
smooth muscle sensitivity to NO because NMN did not influence dilation
in response to administration of a NO donor (sodium nitroprusside), that
is, a dilation that is not induced by endothelial NO production (Seals
et al., 2011).
Our results also suggest that the effects of aging and NMN
supplementation on endothelial function were mediated by differences
in oxidative stress. Consistent with our previous work (Rippe et al., 2010;
Sindler et al., 2011; Fleenor et al., 2013; Gano et al., 2014), pharma-
cofunctional experiments revealed that arteries from old untreated mice
showed a complete restoration of maximal EDD in the presence of the
superoxide dismutase mimetic, TEMPOL, indicating that excessive
superoxide-related oxidative stress was the cause of the age-associated
impairment of EDD (Fig. 2A). Importantly, in contrast to the untreated
old mice, TEMPOL caused no improvement in EDD in old mice receiving
NMN treatment, suggesting that NMN supplementation restored EDD in
the old animals by abolishing superoxide-mediated suppression of
endothelial function with aging. This finding is in agreement with other
interventions that restore EDD with aging (Rippe et al., 2010; Sindler
et al., 2011; Fleenor et al., 2013; Gano et al., 2014).
These function-based observations are supported by our direct
assessments of arterial superoxide production using EPR spectroscopy,
as well as our results for nitrotyrosine, a well-established cellular marker of
oxidative stress (Csiszar et al., 2002; Sindler et al., 2011; Fleenor et al.,
2012a; Donato et al., 2013). Aging in control animalswas associatedwith
marked increases in both aortic superoxide production and nitrotyrosine
abundance (Fig. 2B,C), as we have reported previously (Rippe et al.,
2010; Sindler et al., 2011; Fleenor et al., 2012a, 2013; Donato et al.,
2013; LaRocca et al., 2013). In response to NMN supplementation, we
observed a normalization of aortic superoxide production and a marked
reduction in nitrotyrosine abundance in old mice. Moreover, arteries
incubated in NMN for 48 h had a 50% increase in MnSOD staining
(Fig. 5B), suggesting that the reduction in oxidative stress is likely due, in
part, to an increase in antioxidant defense mechanisms.
Collectively, these findings support the hypothesis that oxidative
stress is a key contributor to age-associated endothelial dysfunction and
suggest that the suppression of oxidative stress may be a major
mechanism by which NMN exerts its beneficial effects on endothelial
function in old animals. These observations are consistent with our
previous findings in young and old mice subjected to a similar duration
of CR (Rippe et al., 2010). Moreover, as recently reported by our
laboratory, the SIRT1 activator, SRT1720, may also be effective in
reversing age-associated endothelial dysfunction by reducing oxidative
stress, albeit with different effects on NO (Gano et al., 2014).
NMN reduces large elastic artery stiffness
Increased stiffening of the large elastic arteries occurs with advancing
age and is a major independent risk factor for age-associated CV events
and clinical CVD (Reddy et al., 2003; Sutton-Tyrrell et al., 2005; Fleenor
et al., 2012b). Increased aortic stiffness, in particular, reduces the ability
to buffer increases in pressure produced by systolic ejection of blood into
the large elastic arteries with each cardiac contraction. This increases
systolic blood pressure and arterial pulse pressure (the difference
between systolic and diastolic blood pressure), as well as the ‘pulsatility’
of blood flow, which is transmitted to the microvasculature of vulnerable
high-flow organs such as the brain and kidney, causing end-organ
damage and other pathophysiological effects (Lakatta & Levy, 2003;
Mitchell et al., 2010; Mitchell, 2014). Here, we show that 8 weeks of
NMN supplementation reverses the age-associated increase in two
functional indices of aortic stiffness: aPWV, the gold standard clinical
measure of large elastic artery stiffness (Mitchell et al., 2010; Vla-
chopoulos et al., 2010), and the elastic modulus, an in vitro measure of
the intrinsic mechanical properties of arteries (Humphrey, 2002; Akhtar
et al., 2011; Fleenor et al., 2012b) (Fig. 3A,B).
The mechanisms by which arteries stiffen with age are not completely
understood, but are thought to include changes in the composition of
structural proteins within the arterial wall. Collagen (type I) is the primary
load-bearing protein in the arterial wall, and its abundance is increased
with advancing age (Zieman et al., 2005; Diez, 2007; Fleenor et al.,
2012b). In contrast, elastin, the main structural protein conferring
elasticity, is reduced in old arteries (Zieman et al., 2005; Diez, 2007;
Fleenor et al., 2012b). We have previously shown in mice (Fleenor et al.,
2012a) and cultured aortic fibroblasts (Fleenor et al., 2010) that
oxidative stress contributes to some or all of the age-associated
structural changes seen within the arteries. In the present study, we
demonstrate that 8 weeks of NMN supplementation reverses the
accumulation of whole-vessel collagen type I and enhances arterial
elastin in old mice (Fig. 3C,D), suggesting that NMN reduces arterial
stiffness, at least in part, by ameliorating these structural changes that
occur to arteries with advancing age.
We have observed reductions in aortic collagen in old mice subjected
to other short-term late-life behavioral or pharmacological interventions
Fig. 5 NAD+ and MnSOD. (A) NAD+
production in aortas from young mice
incubated in vitro with vehicle or NMN for
48 h (n = 3–5 per group). (B) Manganese
superoxide dismutase (MnSOD) expression
in aortas from old mice incubated in vitro
with vehicle or NMN for 48 h (n = 4–5 per
group). Values normalized to vehicle mean
value. Representative images below. Values
are mean  SEM. Bars = 100 lm.
*P < 0.05.
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(Fleenor et al., 2010, 2012a, 2013; LaRocca et al., 2013), although not
in every case (Fleenor et al., 2012b). Interestingly, NMN also induced a
partial restoration of aortic elastin to levels not significantly different
from young control animals. We have not previously observed an
increase in aortic elastin with any other late-life lifestyle or pharmaco-
logical intervention in mice (Fleenor et al., 2010, 2012a,b), although
lifelong CR protects against the loss of elastic properties within the
arteries, including elastin degradation (Fornieri et al., 1999; Donato
et al., 2013). Thus, it is possible that NMN may partially restore the loss
of arterial elastin by mimicking the effects of CR, although further
studies would be needed to provide direct support for this mechanism.
Activation of SIRT1 by NMN
NAD+ bioavailability decreases with age in a number of mammalian
tissues (Yoshino et al., 2011; Gomes et al., 2013; Stein & Imai, 2014),
and administration of NMN increases NAD+ bioavailability in preclinical
models of aging (Yoshino et al., 2011; Gomes et al., 2013; Stein & Imai,
2014). Enhancing NAD+ biosynthesis with NAD+ precursors such as NMN
and nicotinamide riboside increases the activity of the NAD+-dependent
deacetylase SIRT1 (Imai, 2010; Satoh et al., 2011; Yoshino et al., 2011;
Canto et al., 2012). In the present study, short-term (48-h) incubation of
NMN resulted in a threefold increase in aortic NAD+ levels (Fig. 5A),
indicating that NMN is directly taken up by the aorta and converted to
NAD+. This is consistent with previous reports that NMN increases NAD+
in cultured vascular endothelial cells (Hughes-Large et al., 2014) and
normalizes the ratio of NAD+/NADH in aortic tissue (Marcu et al., 2015).
Oral supplementation with NMN increased SIRT1 protein expression in
young and tended to increase SIRT1 in old mice (Fig. 4A). We have
observed an increase in SIRT1 expression previously in animals supple-
mented with the SIRT1 activator, SRT1720 (Gano et al., 2014). SIRT1
promotes autotranscriptional regulation of itself through enhanced
deacetylation and activity of transcription factors, such as Forkhead
transcription factor FoxO1, resulting in elevated SIRT1 protein expression
(Xiong et al., 2011). Moreover, in the current study, supplementa-
tion with NMN restored the activity of SIRT1 in the arteries of old mice to
that of young controls, as indicated by a decrease in the ratio of
acetylated to total p65 subunit of the transcription factor NFjB (Fig. 4B),
a well-established target of SIRT1 (Yoshino et al., 2011; Gano et al.,
2014). Although measuring the acetylation status of downstream targets
of SIRT1 is an accepted method of assessing activity of the enzyme
(Yoshino et al., 2011; Gano et al., 2014), protein acetylation is
influenced by additional factors, such as acetyltransferases and deacety-
lases other than sirtuins (Peserico & Simone, 2011). Thus, it is possible
that the ratio of acetylated to total p65 was due, in part, to other
mechanisms. However, the current results are consistent with SIRT1
activation as the primary mechanism, as reported previously by our
laboratory and others (Yoshino et al., 2011; Gano et al., 2014).
In addition to activating SIRT1, it is possible that NMN reduced
oxidative stress and improved vascular function in old animals by
modulating other pathways. For example, NMN may have influenced
the activity of additional sirtuins, such as mitochondrial SIRT3, which is
associated with decreased oxidative stress and enhanced physiological
function (Someya et al., 2010). It is also possible that NMN enhanced
metabolic flux through the tricarboxylic acid cycle and electron transport
chain, thus reducing cellular reactive oxygen species (Nakamura et al.,
2012). Moreover, NMN could have increased NADPH levels, which help
maintain the glutathione and thioredoxin antioxidant systems (Naka-
mura et al., 2012). Finally, NMN may have improved other adverse
influences on vascular health, such as plasma lipid profiles or blood
glucose levels, thereby improving vascular function. Future investigation
is warranted to study these possibilities.
Conclusion
The results of this study provide the first evidence that oral supplemen-
tation with NMN represents a novel strategy for combating arterial aging
and its pathological sequelae.
Experimental procedures
Animals
Young (4–8 months) C57Bl/6 male mice were purchased from Charles
River, and old (26–28 months) C57Bl/6 male mice were obtained from
the National Institute on Aging rodent colony. Mice were fed normal
rodent chow ad libitum for the duration of the study. After a 2-week
acclimation period, the young and old mice were divided into two
subgroups: control animals (YC, OC) continued on normal drinking
water and the other animals (YNMN, ONMN) received nicotinamide
mononucleotide (NMN; Sigma-Aldrich Corp., St. Louis, MO, USA) in the
drinking water (target dose of 300 mg kg1 day1) for 8 weeks. Body
mass and water intake were monitored three times per week, and NMN
concentration in the drinking water was adjusted to account for water
intake. All mice were housed in an animal care facility at the University of
Colorado Boulder on a 12-hour: 12-hour light–dark cycle. All animal
procedures conformed to the Guide to the Care and Use of Laboratory
Animals (NIH publication n. 85-23, revised 1996) and were approved by
the UCB Animal Care and Use Committee.
Ex vivo carotid artery vasodilatory responses
Endothelium-dependent dilation and endothelium-independent dilation
were determined ex vivo in isolated carotid arteries as previously described
(Rippe et al., 2010; Sindler et al., 2011). Mice were anesthetized using
isoflurane and euthanized by exsanguination via cardiac puncture. The
carotid arteries were excised, cannulated onto glass micropipette tips, and
secured with nylon (11-0) sutures in individual myograph chambers (DMT
Inc., Ann Arbor, MI, USA) containing buffered physiological saline
solutions. The arterieswere pressurized to 50 mmHgat 37 °C and allowed
to equilibrate for 45 min before experimentation. After submaximal
preconstrictionwith phenylephrine (2 lM), increases in luminal diameter in
response to acetylcholine (ACh: 1 9 109  1 9 104 M; Sigma-Aldrich
Corp.)with andwithout co-administration of theNO synthase inhibitor, N-
G-nitro-L-arginine-methyl ester (L-NAME, 0.1 mM, 30-min incubation;
Sigma-Aldrich Corp.) or the superoxide dismutase mimetic 4-Hydroxy-
2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPOL, 0.1 mM, 1-h incubation;
Sigma-Aldrich Corp.) were determined. Endothelium-independent dila-
tion was determined by vasodilation in response to the NO donor sodium
nitroprusside (SNP: 19 1010  19 104 M; Sigma-Aldrich Corp.).
All dose–response data are presented as percent dilation as described
previously (Rippe et al., 2010; Sindler et al., 2011). Preconstriction was
calculated as a percent of maximal intraluminal diameter according to
the following formula:
Preconstriction ð%Þ ¼ Dm  Db
Dm
 100:
Because of differences in maximal carotid artery diameter between
young and old animals, vasodilator responses were recorded as actual
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diameters expressed as a percent of maximal response according to the
following formula:
Dilation ð%Þ ¼ Ds  Db
Dm  Db
 100:
where Dm is maximal intraluminal diameter at 50 mmHg, Db is the
steady-state intraluminal diameter following preconstriction before the
first addition of a drug, and Ds is the steady-state intraluminal diameter
recorded after the addition of a drug.
NO-dependent dilation was determined from maximal EDD (i.e.,
dilation with the highest dose [1 9 104 M] ACh) in the absence or
presence of L-NAME according to the following formula:
NO-dependent dilation ð%Þ ¼ Maximum dilationACh
Maximal dilationACh þ L  NAME:
In vivo aortic pulse wave velocity
Aortic pulse wave velocity (aPWV) was measured as described
previously (Sindler et al., 2011; Fleenor et al., 2012b). Mice were
anesthetized with 2% isoflurane and placed supine with legs secured
to electrocardiogram (ECG) electrodes. Aortic blood flow velocity was
measured with Doppler probes at the transverse aortic arch and
abdominal aorta. Pre-ejection time, the time between the R-wave of
the ECG to foot of the Doppler signal, was determined for each site.
aPWV was calculated by dividing the distance between the transverse
and abdominal probes by the difference in the thoracic and abdominal
pre-ejection times.
In vitro elastic modulus
In vitro intrinsic mechanical properties of the thoracic aorta were used to
calculate the elastic modulus as previously described (Fleenor et al.,
2012b). Aortic segments (~1.5 mm), cleaned of perivascular fat and other
surrounding tissue, were loaded onto a calibrated, preheated (37 °C) wire
myograph chamber (DMT Inc.) containing calcium-free phosphate-
buffered saline. The segments were prestretched for 3 min to a 1-mm
luminal diameter displacement that was returned to the nonstretched
baseline, and this was repeated twice. The segments were then stretched
to a baseline force of 1 mN. Luminal displacement was increased
incrementally (~ 10%) every 3 min, and the force was recorded after
each time period. Displacement was increased until mechanical failure of
the tissue occurred, defined by an observed transient decrease in force.
Stress and strainwere calculatedwhere stresswas defined as: t = kL/2HD.
t = one-dimensional stress, k = strain, L = one-dimensional load applied,
H = wall thickness, D = length of vessel. Strain was defined as: k = Dd/d
(i). k = strain, Dd = change in diameter, d(i) = initial diameter. The slope
of the stress–strain curve was used to determine the elastic modulus as
previously described (Fleenor et al., 2012b).
Aortic superoxide production
Superoxide production in the thoracic aorta was measured using EPR
spectroscopy, as previously described (Sindler et al., 2011; Fleenor et al.,
2012b; LaRocca et al., 2013). One-millimeter aortic segments, free of
perivascular fat and other surrounding tissue, were incubated for 1 h
at 37 °C in Krebs–Hepes buffer with the superoxide-specific spin probe
1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH; 0.5
mM; Enzo Life Sciences, Inc., Farmington, NY, USA) for detection of
whole-cell superoxide production. The signal amplitude was analyzed
using an MS300 X-band EPR spectrometer (Magnettech GmbH, Berlin,
Germany) with the following settings: centerfield, 3350 G; sweep, 80 G;
microwave modulation, 3000 mG, and microwave attenuation, 7 dB as
described previously (Sindler et al., 2011; Fleenor et al., 2012b; LaRocca
et al., 2013). Data are presented relative to the YC group mean.
Western blotting
Aortas were used as a surrogate large elastic artery to provide sufficient
tissue for analysis of protein expression by Western blot as described
previously (Sindler et al., 2011; Donato et al., 2013; LaRocca et al.,
2013; Gano et al., 2014). Aortas, cleared of perivascular fat and other
surrounding tissues, were frozen in liquid nitrogen before storage at
80 °C. The tissue was homogenized in ice-cold Radioimmunoprecip-
itation assay (RIPA) lysis buffer containing protease and phosphatase
inhibitors [Protease Inhibitor Cocktail Tablet (Roche, Indianapolis, IN,
USA) and 0.01% phosphatase inhibitor cocktail (Sigma-Aldrich Corp.)]
and pulverized using a Bullet Blender. Protein was loaded on 4–12%
polyacrylamide gels (12 lg per well), separated by electrophoresis, and
transferred onto nitrocellulose membranes (Criterion System; Bio-Rad
Laboratories, Inc., Hercules, CA, USA) for Western blot analysis.
Membranes were incubated with the following primary antibodies
overnight at 4 °C: nitrotyrosine (NT 1:500; Abcam, Cambridge, MA,
USA), sirtuin1 (SIRT1 1:1000; Abcam), p65 subunit of nuclear factor
kappa B (NFjB; 1:500 Cell Signaling Technology Inc., Danvers, MA,
USA), and acetylated p65 subunit of nuclear factor kappa B (ac-NFjB;
1:500 Cell Signaling Technology Inc.). Proteins were visualized on a
digital acquisition system (ChemiDoc-It; UVP, Inc., Upland, CA, USA)
using chemiluminescence with horseradish peroxidase-conjugated sec-
ondary antibodies (Jackson ImmunoResearch Laboratories, Inc., West
grove, PA, USA) and enhanced chemiluminescence (ECL) substrate
(Pierce Biotechnology, Inc., Rockford, IL, USA). Relative intensity was
quantified using ImageJ software version 1.0 (National Institutes of
Health). All data were normalized to expression of alpha smooth muscle
actin (a actin 1:5000; Abcam). The ratio of acetylated to total p65 was
determined using two identical Western blots: one probed for acetylated
p65, and the other probed for total p65. Each value was normalized to a
actin in the corresponding gel. The ratio of acetylated to total p65 was
determined for each animal and then normalized to the YC group mean.
In vitro NMN incubation
Aortas, cleaned of perivascular fat and other surrounding tissue, were cut
into equal segments and incubated in glucose- and nicotinamide-free
Dulbecco’s modified Eagle medium (DMEM) control media (modification
of Life Technologies #10566) with glucose (5 mM) and nicotinamide
(1 lM) added to reflect physiologically relevant concentrations (Ramsey
et al., 2008), with or without NMN (100 lM) for 48 h, and then either
immediately frozen in liquid nitrogen for assessment of aortic NAD+
concentration, or embedded and frozen in optimal cutting temperature
compound (OCT; Fisher Scientific Inc.,Waltham,MA,USA) for assessment
of MnSOD expression using immunohistochemistry as described below.
NAD+ measurement
Aortic NAD+ levels were determined in young (12 month) mice using an
HPLC system (Shimadzu, Kyoto, Japan) with a Supelco LC-18-T column
(15 cm 9 4.6 cm; Sigma-Aldrich Corp.) as described previously
(Yoshino et al., 2011).
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Immunohistochemistry
Immunohistochemistry was used to determine aortic expression of
collagen type I, elastin, and MnSOD as previously described (Fleenor
et al., 2010, 2012b). Thoracic aorta segments, cleared of perivascular fat
and other surrounding tissue, were frozen in OCT compound in liquid
nitrogen-cooled isopentane. Seven-micrometer aortic segments were
fixed in acetone for 10 min and washed in Tris buffer. All slides were
stained with the Dako EnVision + System-HRP-DAB-kit according to the
manufacturer’s protocol using the following primary antibodies: collagen
type 1 (Col I; 1:100, Millipore Corp., Temecula, CA, USA), alpha elastin
(a elastin; 1:50, Abcam), and MnSOD (1:500, StressGen Biotechnolo-
gies). Primary antibodies were incubated for 1 h at 4 °C. The labeled
polymer was applied for 30 min, and staining was visualized after a
4-min exposure to diaminobenzidine (DAB). Slides were then dehydrated
and coverslipped. Digital photomicrographs were obtained using a Nikon
Eclipse TS100 photomicroscope, and quantification was performed with
ImageJ software version 1.0. Slides from multiple batches were
normalized to the same representative YC/vehicle animal and normalized
to the YC/vehicle mean of each staining day.
Statistical analyses
Data are presented as mean  SEM in text, figures, and tables. All
analyses were performed with SPSS. Student’s t-test was used to analyze
aortic NAD+ and MnSOD. A one-way ANOVA was used to analyze
morphological characteristics, maximum EDD, NO-mediated EDD, EPR
spectroscopy, aPWV, elastic modulus, Western blots, and immunohis-
tochemistry. Within-group differences in the maximal EDD dose–
response to acetylcholine in the absence vs. presence of TEMPOL was
determined using two-factor (group 9 treatment) repeated-measures
ANOVA. When a significant main effect was observed, Tukey post hoc
tests were used to determine specific pairwise differences. Significance
was set at P < 0.05.
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